SHINE Building One 90 Day Progress

2017-10-18T14:34:56+00:00

Building One construction continues on schedule! Over 60 on-site work days with 0 accidents. Way to go JP Cullen! To view our other videos, visit our YouTube channel and hit subscribe to see the most recent and future updates.

SHINE Building One 90 Day Progress 2017-10-18T14:34:56+00:00

Grand Opening of new SHINE Global HQ

2017-08-01T08:31:03+00:00

January 16, 2017 - SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a ribbon cutting ceremony to celebrate the grand opening of the company’s new global headquarters in downtown Janesville, Wisconsin. The ribbon cutting was led by the John Beckord and the Forward Janesville Goodwill Ambassadors.

Grand Opening of new SHINE Global HQ 2017-08-01T08:31:03+00:00

SHINE to Hold Information Session

2017-08-01T08:50:16+00:00

SHINE Medical Technologies, Inc. (SHINE Medical), a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes and cancer treatment elements, announced today that it will present an update on its progress in the development and planning for its Janesville medical isotope facility on Wednesday, June 18th at the Holiday Inn Express, 3100 Wellington Place in Janesville.

SHINE to Hold Information Session 2017-08-01T08:50:16+00:00

James L. Connaughton Joins SHINE

2017-08-01T08:50:34+00:00

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, announced today that James L. Connaughton has agreed to serve as a strategic advisor to management as SHINE continues its efforts to bring molybdenum-99 (moly-99) to market.

James L. Connaughton Joins SHINE 2017-08-01T08:50:34+00:00

SHINE to Supply Mo-99 to GE Healthcare

2017-08-01T08:50:48+00:00

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin‐based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, announced today that it has entered into a strategic long‐term supply agreement with GE Healthcare, a division of the General Electric Company, for supply of molybdenum‐99 (moly‐99).

SHINE to Supply Mo-99 to GE Healthcare 2017-08-01T08:50:48+00:00

SHINE Construction Permit Application Accepted by NRC

2017-09-18T13:31:20+00:00

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes and cancer treatment elements, announced today that the Nuclear Regulatory Commission (NRC) has accepted for review the second half of SHINE’s construction permit application to build a medical isotope production plant near Janesville, WI.

SHINE Construction Permit Application Accepted by NRC 2017-09-18T13:31:20+00:00

NRC Dockets SHINE Construction Permit Application

2017-09-18T13:30:34+00:00

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, and affordable production of medical isotopes and cancer treatment elements, has received notice that the Nuclear Regulatory Commission (NRC) has accepted the first part of its Construction Permit application for review and docketing. This is the first formal step by the NRC in the construction permitting process for the SHINE medical isotope facility in Janesville, Wisconsin.

NRC Dockets SHINE Construction Permit Application 2017-09-18T13:30:34+00:00

SHINE to Hold Information Session

2017-09-25T09:34:23+00:00

SHINE Medical Technologies, Inc. (SHINE Medical), a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes and cancer treatment elements, announced today that it will present an update on its progress in the development and planning for its Janesville medical isotope facility on Thursday, June 13th at the Holiday Inn Express, 3100 Wellington Place in Janesville.

SHINE to Hold Information Session 2017-09-25T09:34:23+00:00

SHINE Files 2nd Part of NRC Construction Permit Application

2017-08-01T08:53:08+00:00

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, and affordable production of medical isotopes and cancer treatment elements, has submitted the remaining chapters of its Construction Permit application to the Nuclear Regulatory Commission (NRC).

SHINE Files 2nd Part of NRC Construction Permit Application 2017-08-01T08:53:08+00:00